Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Nutr Hosp ; 33(4): 381, 2016 Jul 19.
Artigo em Inglês | MEDLINE | ID: mdl-27571659

RESUMO

INTRODUCTION: The rise in prevalence of obesity has occurred concomitantly to that of vitamin D deficiency (VDD). The aim of this narrative review was to describe the relationship between obesity and such related diseases as VDD in adolescents, in an effort to warn of the risks of this deficiency during this period of growth and development. METHODS: We searched the electronic databases PubMed, Medline, Scielo, Science Direct and Lilacs for articles from between 2000 and 2015 on the topics obesity and obesity-related diseases and VDD in adolescents. We included articles written in English, Spanish and Portuguese of the analytical variety (transverse and longitudinal), systematic reviews, meta-analysis and controlled clinical trials on humans, and excluded studies that were done on animals, inconclusive or with undefined methodology. RESULTS: We produced an overview of VDD in obesity, in cardiovascular diseases, in diabetes mellitus, in systemic hypertension, and in dyslipidemia. The prevalence of VDD was considered high in obese adolescents and their relationship with the obesity and related diseases was found in adolescents. These findings forewarn of possible clinical repercussions in the health of the adolescents, foremost because of how essential vitamin D is to growth and development, and for its interaction with obesity and obesity-related diseases. CONCLUSION: The worldwide rise in the obesity rate alongside the progressively increasing of vitamin D deficiency in adolescents is alarming. This relationship of VDD with the obesity and related diseases was found in adolescents. Vitamin D supplementation is considered promising measure to take with obese adolescents.


Assuntos
Obesidade/complicações , Deficiência de Vitaminas do Complexo B/complicações , Adolescente , Feminino , Humanos , Masculino , Obesidade/epidemiologia , Deficiência de Vitaminas do Complexo B/epidemiologia
2.
Nutr. hosp ; 33(4): 856-864, jul.-ago. 2016.
Artigo em Inglês | IBECS | ID: ibc-154911

RESUMO

Introduction: the rise in prevalence of obesity has occurred concomitantly to that of vitamin D deficiency (VDD). The aim of this narrative eview was to describe the relationship between obesity and such related diseases as VDD in adolescents, in an effort to warn of the risks of this defi ciency during this period of growth and development. Methods: We searched the electronic databases PubMed, Medline, Scielo, Science Direct and Lilacs for articles from between 2000 and 2015 on the topics obesity and obesity-related diseases and VDD in adolescents. We included articles written in English, Spanish and Portuguese of the analytical variety (transverse and longitudinal), systematic reviews, meta-analysis and controlled clinical trials on humans, and excluded studies that were done on animals, inconclusive or with undefi ned methodology. Results: We produced an overview of VDD in obesity, in cardiovascular diseases, in type 2 diabetes mellitus, in systemic hypertension, and n dyslipidemia. The prevalence of VDD was considered high in obese adolescents and their relationship with the obesity and related diseases was found in adolescents. These findings forewarn of possible clinical repercussions in the health of the adolescents, foremost because of how essential vitamin D is to growth and development, and for its interaction with obesity and obesity-related diseases. Conclusion: The worldwide rise in the obesity rate alongside the progressively increasing of vitamin D deficiency in adolescents is alarming. This relationship of VDD with the obesity and related diseases was found in adolescents. Vitamin D supplementation is considered promising measure to take with obese adolescents (AU)


Introducción: el aumento de la prevalencia de la obesidad se ha producido de forma concomitante a la deficiencia de vitamina D (DVD). El bjetivo de esta revisión fue describir la relación entre la obesidad y las patologías asociadas a la obesidad y la DVD en adolescentes, en un esfuerzo por advertir los riesgos de esta deficiencia durante este periodo de crecimiento y desarrollo. Métodos: se realizaron búsquedas en las bases de datos electrónicas PubMed, Medline, Scielo, Science Direct y Lilacs para los artículos de entre 2000 y 2015 sobre temas como la obesidad y las patologías asociadas a la obesidad y DVD en adolescentes. Se incluyeron artículos escritos en inglés, español y portugués de la variedad analítica (transversal y longitudinal), revisiones sistemáticas, metaanálisis y ensayos clínicos controlados en seres humanos, y excluyendo los estudios que se realizan en animales, no concluyentes o con metodología indefinida. Resultados: se produjo una visión general de DVD en la obesidad, las enfermedades cardiovasculares, la diabetes mellitus, la hipertensión sistémica y en la dislipidemia. La prevalencia de DVD se considera alta en adolescentes obesos y su relación con las patologías asociadas a la obesidad fueran encontradas en adolescentes. Estos datos advierten sobre posibles repercusiones clínicas en la salud de los adolescentes, sobre todo debido a la forma esencial de vitamina D en el crecimiento y el desarrollo, y por su interacción con la obesidad y las patologías asociadas a la obesidad. Conclusión: el aumento mundial de la tasa de obesidad junto con el aumento progresivo de la defi ciencia de vitamina D en los adolescentes es alarmante. Se encontró una relación en adolescentes entre VDD y obesidad y enfermedades relacionadas. La suplementación de vitamina D se considera una medida promisoria para tratar a los adolescentes obesos (AU)


Assuntos
Humanos , Masculino , Feminino , Adolescente , Deficiência de Vitamina D/complicações , Deficiência de Vitamina D/fisiopatologia , Obesidade/complicações , Obesidade/dietoterapia , Obesidade/fisiopatologia , Fatores de Risco , Doenças Cardiovasculares/complicações , Doenças Cardiovasculares/prevenção & controle , Estudos Transversais/métodos , Estudos Transversais , Estudos Longitudinais , Bibliometria , Hepatopatia Gordurosa não Alcoólica/complicações , Diabetes Mellitus Tipo 2/complicações , Hipertensão/complicações , Dislipidemias/complicações
3.
ABCD (São Paulo, Impr.) ; 25(4): 250-256, out.-dez. 2012. graf, tab
Artigo em Português | LILACS | ID: lil-665741

RESUMO

RACIONAL: A vitamina A participa de várias funções primordiais no organismo humano e as suas concentrações séricas podem estar diminuídas nas doenças crônicas não transmissíveis. OBJETIVO: Avaliar a relação entre o estado nutricional da vitamina A, e a regressão da esteatose hepática em indivíduos submetidos à gastroplastia em Y-de-Roux para tratamento da obesidade classe III. MÉTODOS: Foram estudados 30 pacientes obesos classe III, de ambos os sexos, com esteatose hepática, submetidos à gastroplastia em Y-de-Roux. Seis meses após a operação, os pacientes foram submetidos à ultrassonografia abdominal e distribuídos em dois grupos: grupo 1 - pacientes com esteatose detectada na ultrassonografia e grupo 2 - pacientes sem esteatose detectada na ultrassonografia. No pré-operatório e seis meses após a operação foram realizadas análises antropométricas e exames bioquímicos: insulina basal, glicemia, Homeostasis Model Assessment Index (HOMA IR), colesterol, HDL, LDL, triglicerídeos, AST, ALT, Gama-GT, albumina, bilirrubina total, retinol, e beta caroteno. RESULTADOS: A média de perda de peso foi de 35,05 + 10,47 (p<0,01) e a diminuição no Índice de Massa Corporal (IMC) de 11,6 + 4,99 Kg/m² (p<0,01). Após seis meses, todos os exames bioquímicos apresentaram diminuição significativa das concentrações (p<0,05). O grupo 2 (sem esteatose) apresentou no pós-operatório, concentrações significativamente inferiores (p<0,05), nas variáveis: peso, IMC, AST, ALT, gama GT, HOMA IR, insulina basal. As concentrações séricas de albumina apresentaram valores médios aproximados, sem diferença significativa nos dois tempos avaliados. Observaram-se concentrações séricas mais elevadas de retinol e de β-caroteno e redução menor em relação as concentrações do pré-operatório nos pacientes sem esteatose, porém sem diferença estatística. CONCLUSÃO: Adequado estado nutricional de vitamina A pode contribuir na regressão da esteatose hepática em pacientes submetidos à Gastroplastia em Y-de-Roux para tratamento da obesidade classe III.


BACKGROUND: Vitamin A participates in several essentials functions in the human body and their serum concentrations may be decreased in non-transmissible diseases. AIM: To assess the relationship of the nutritional status of Vitamin A through the serum concentrations of retinol and beta carotene, with regression of hepatic steatosis in individuals who undergone Roux-en-Y gastric bypass surgery for treatment of class III obesity. METHODS: Were included 30 individuals, male and female, submitted to Roux-en-Y gastric bypass for treatment of class III obesity, who were diagnosed through an abdominal ultrasonography as presenting hepatic steatosis. From the result of an ultrasonography screened six months after the surgical procedure those subjects were divided into two groups: group 1 - patients with steatosis detected in the ultrasonography (16 subjects) and group 2 - patients without steatosis detected in the ultrasonography (14 subjects). Before and six months after the surgery, were carried out anthropometrical analyses and biochemical exams (basal insulin, glicemy, Homeostasis Model Assessment Index (HOMA IR), cholesterol, HDL, LDL, triglycerides, AST, ALT, Gamma-GT, albumin, total bilirubin, retinol, and beta carotene. RESULTS: The individuals presented an average weight loss of 35.05 + 10.47 (p<0.01) and a decrease in the Body Mass Index (BMI) of 11.6 + 4.99 Kg/m² (p<0.01). After six months, all the biochemical exams presented a significant decrease in their basal concentrations (p<0.05). In the post-operative period the group 2 (without steatosis) presented concentrations significantly lower (p<0.05) in the following variables: weight, BMI, AST, ALT, Gamma-GT, HOMA IR, basal insulin. The albumin serum concentrations presented close average values, with no significant difference in the two periods evaluated. In the assessment of retinol and beta carotene, higher serum concentrations and a small decrease in relation to the concentrations of the pre-operative period in the group without steatosis were observed, however, no statistical difference was found. CONCLUSION: An adequate nutritional status of vitamin A might contribute in the improvement of the hepatic esteatosis after Roux-en-Y gastric bypass for class III obesity treatment.


Assuntos
Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Adulto Jovem , Fígado Gorduroso/sangue , Derivação Gástrica , Estado Nutricional , Obesidade Mórbida/sangue , Obesidade Mórbida/cirurgia , Vitamina A/sangue , Fígado Gorduroso/etiologia , Obesidade Mórbida/complicações , Indução de Remissão
4.
Arq Bras Cir Dig ; 25(4): 250-6, 2012.
Artigo em Inglês, Português | MEDLINE | ID: mdl-23411924

RESUMO

BACKGROUND: Vitamin A participates in several essentials functions in the human body and their serum concentrations may be decreased in non-transmissible diseases. AIM: To assess the relationship of the nutritional status of Vitamin A through the serum concentrations of retinol and beta carotene, with regression of hepatic steatosis in individuals who undergone Roux-en-Y gastric bypass surgery for treatment of class III obesity. METHODS: Were included 30 individuals, male and female, submitted to Roux-en-Y gastric bypass for treatment of class III obesity, who were diagnosed through an abdominal ultrasonography as presenting hepatic steatosis. From the result of an ultrasonography screened six months after the surgical procedure those subjects were divided into two groups: group 1 - patients with steatosis detected in the ultrasonography (16 subjects) and group 2 - patients without steatosis detected in the ultrasonography (14 subjects). Before and six months after the surgery, were carried out anthropometrical analyses and biochemical exams (basal insulin, glicemy, Homeostasis Model Assessment Index (HOMA IR), cholesterol, HDL, LDL, triglycerides, AST, ALT, Gamma-GT, albumin, total bilirubin, retinol, and beta carotene. RESULTS: The individuals presented an average weight loss of 35.05 + 10.47 (p<0.01) and a decrease in the Body Mass Index (BMI) of 11.6 + 4.99 Kg/m² (p<0.01). After six months, all the biochemical exams presented a significant decrease in their basal concentrations (p<0.05). In the post-operative period the group 2 (without steatosis) presented concentrations significantly lower (p<0.05) in the following variables: weight, BMI, AST, ALT, Gamma-GT, HOMA IR, basal insulin. The albumin serum concentrations presented close average values, with no significant difference in the two periods evaluated. In the assessment of retinol and beta carotene, higher serum concentrations and a small decrease in relation to the concentrations of the pre-operative period in the group without steatosis were observed, however, no statistical difference was found. CONCLUSION: An adequate nutritional status of vitamin A might contribute in the improvement of the hepatic esteatosis after Roux-en-Y gastric bypass for class III obesity treatment.


Assuntos
Fígado Gorduroso/sangue , Derivação Gástrica , Estado Nutricional , Obesidade Mórbida/sangue , Obesidade Mórbida/cirurgia , Vitamina A/sangue , Adulto , Fígado Gorduroso/etiologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Obesidade Mórbida/complicações , Indução de Remissão , Adulto Jovem
5.
Rev. bras. cir ; 76(4): 215-9, jul.-ago. 1986. ilus
Artigo em Português | LILACS | ID: lil-37033

RESUMO

Em 50 pacientes determinou-se o pH do suco gástrico após doses seqüenciais de cimetidine, administrada por via intramuscular e intravenosa. Os valores obtidos demonstram que a droga, administrada por essas vias, näo atinge níveis terapêuticos, sendo a via intravenosa a única realmente eficaz. Esta eficácia, todavia, só é uniforme entre a segunda e a quarta horas após o estímulo. Dois pacientes näo tiveram seu pH intragástrico aumentado mesmo após o emprego de doses elevadas. A administraçäo a intervalos de seis horas produz com freqüência uma curva de pH em "S" e deve ser usada somente em casos selecionados, com monitoraçäo da acidez gástrica. O emprego a intervalos de quatro horas provavelmente oferece melhor proteçäo contra lesöes agudas da mucosa gástrica, pépticas ou näo pépticas


Assuntos
Lactente , Pré-Escolar , Criança , Adolescente , Humanos , Masculino , Feminino , Cimetidina/administração & dosagem , Suco Gástrico/análise , Concentração de Íons de Hidrogênio
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...